| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |